載入...
Complement C5-inhibiting therapy for the thrombotic microangiopathies: accumulating evidence, but not a panacea
Thrombotic microangiopathy (TMA), characterized by organ injury occurring consequent to severe endothelial damage, can manifest in a diverse range of diseases. In complement-mediated atypical haemolytic uraemic syndrome (aHUS) a primary defect in complement, such as a mutation or autoantibody leadin...
Na minha lista:
| 發表在: | Clin Kidney J |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Oxford University Press
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5622895/ https://ncbi.nlm.nih.gov/pubmed/28980670 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ckj/sfx081 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|